All Type of News
SK Chemical took approval of an anti-coagulation drug.
SK Chemical and SK Pharmaceutical secured the KFDA approval of "Hootan", an anti-coagulation drug, for the treatment of blood coagulation and thrombo-embolism for patients on blood dialysis and acute pancreatitis, on ...
Boryung to set up SCM system.
Boryung Pharm. Co. announced that for the first time in the pharmaceutical industry of Korea they launched SCM (supply chain management) system in their purchase works, providing a package form of internet logistic se...
KFDA revises regulations on novel salt preparations
A person who intends to obtain a manufacturing license for novel salt preparations should submit bioequivalence-tested data to the Korea Food and Drug Administration. But in the case of product approval for generic ve...
Drug identification system for capsule to take place in 2005
The Korea Food and Drug Administration said it has readjusted its implementation period of the new drug identification system for dosage forms with the following schedules: capsule form (from January 1, 2005), film-co...
Sanofi-Synthelabo launches Cronosphere, innovative anti-epileptic drug
Sanofi-Synthelabo said it has launched Cronosphere, a novel dosage form of Depakine (sodium valproate) for the treatment of epilepsy.
Cronosphere is a sustained release dosage form using a prilling method.
Sphe...
815 drugs to be incentive items for substituted dispensing.
About 815 drugs could be under the category of "Incentive items for cheaper substituted dispensing" as of the end of May this year, which gives an incentive at about 30% out of the price differences of the cheap subst...
Domestic pharmaceutical industry rushes to expand global operations
Korea's pharmaceutical firms, including a major business interest group, are scurrying to expand their foreign operations in a bid to strength their presence in the global market beyond already saturated domestic phar...
Medium- and small-sized pharmaceutical firms now turn to Internet
Amid depressed consumer demand and a slumping economy, sales of domestic medium- and small-sized pharmaceutical firms involved in functional health foods and cosmetics, via Internet community and on-line shopping mall...
Zelmac monotherapy shows promise in irritable bowel syndrome
The single treatment of Zelmac (tegaserod), a drug for the treatment of abdominal pain or discomfort and constipation in women with irritable bowel syndrome (IBS) being developed by Switzerland-based Novartis, could b...
Preoccupation of lst generic drug registration in hot competition.
Most of leading domestic pharmaceutical companies are in severe competition for earlier registration of the copy products whose patents be terminated than the rivals in view of preoccupying the already well establishe...
